ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

NCI T Fund New Effort By Cooperative Groups To Extend Treatment Into Community Hospitals

March 5, 1976

Foundation sees Grants Applications On Chronic Conditions

February 16, 1996

Book For Survivors, Other New Publications

August 23, 1991

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012